Sep-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Quality Drugs has shown a fluctuating performance in the Edible category in Oregon. Starting from June 2025, the brand was ranked 11th, improving to 9th place in July, indicating a positive trend during the mid-summer period. However, by August, the rank slipped back to 12th, and further declined to 13th in September. This downward trend suggests challenges in maintaining momentum as the summer season waned, despite an initial boost in sales. The sales figures reflect this pattern, with a peak in July followed by a decrease in the subsequent months.
The absence of Quality Drugs in the top 30 rankings for months other than those highlighted in Oregon could be seen as a concern, particularly if the brand aims to establish a stronghold in the Edible category within this state. The fluctuation in rankings and sales might indicate a need for strategic adjustments to maintain competitiveness and capitalize on market opportunities. Observing these movements provides insights into how Quality Drugs might navigate future market dynamics and consumer preferences in the Edibles segment.
Competitive Landscape
In the competitive landscape of the Oregon edible cannabis market, Quality Drugs has experienced notable fluctuations in its ranking over the past few months. Starting in June 2025, Quality Drugs held the 11th position, but by September 2025, it had slipped to 13th place. This decline is significant, especially when compared to competitors like Feel Goods, which improved its rank from 13th in June to 9th in August before settling at 11th in September. Meanwhile, Verdant Leaf Farms maintained a relatively stable position, consistently ranking around 12th, except for a brief dip to 14th in August. Golden and Dr. Feel Good also hovered around the mid-teens, with Golden consistently ranking 15th and Dr. Feel Good fluctuating between 13th and 16th. These dynamics suggest that while Quality Drugs has maintained a competitive position, it faces challenges in sustaining its rank amidst aggressive competition and shifting consumer preferences.
Notable Products
In September 2025, the top-performing product for Quality Drugs was the Mellow Mango Gummy (100mg), which climbed to the first position in the rankings with sales of 2478 units. Following closely, the Super Sour Apple Gummy (100mg) held the second spot, showing a decline from its top position in August. The Lifted Lime Gummy (100mg) secured the third rank, experiencing a slight drop from its previous second-place standing. Watermelon Gummy (100mg) re-entered the rankings at fourth position, while Assorted Fruit Chews 10-Pack (100mg) slipped to fifth, marking a consistent decline over the months. This reshuffling highlights the dynamic shifts in consumer preferences within the Edible category.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.